Investor s Fiduciary Advisor Network LLC Purchases Shares of 5,182 Danaher Corporation $DHR

Key Points

• Investor’s Fiduciary Advisor Network LLC acquired 5,182 Danaher shares during the second quarter, valued at approximately $987,000.
• Institutional investors own 79.05% of Danaher, with several major firms—including BlackRock, Norges Bank and Generation Investment Management—recently establishing or expanding positions.
• Danaher exceeded quarterly expectations with adjusted EPS of $1.94 and revenue of $6.26 billion, while analysts maintain a “Moderate Buy” consensus and an average price target of $228.91.

Investor s Fiduciary Advisor Network LLC acquired a new position in Danaher Corporation (NYSE:DHR - Free Report) during the second quarter, according to its most recent filing with the SEC. The firm acquired 5,182 shares of the conglomerate's stock, valued at approximately $987,000.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. BlackRock Inc. bought a new stake in Danaher in the second quarter valued at $10,492,520,000. Norges Bank bought a new stake in shares of Danaher during the 4th quarter valued at about $2,177,106,000. Generation Investment Management LLP purchased a new position in shares of Danaher during the second quarter valued at about $1,287,949,000. Flossbach Von Storch SE bought a new position in Danaher in the second quarter worth about $747,260,000. Finally, Bank of New York Mellon Corp purchased a new stake in Danaher in the second quarter worth about $712,875,000. Institutional investors own 79.05% of the company's stock.

Danaher Price Performance

Shares of NYSE:DHR opened at $219.42 on Monday. The business has a fifty day moving average price of $195.80 and a 200-day moving average price of $192.40. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.65 and a quick ratio of 1.25. The company has a market capitalization of $154.25 billion, a PE ratio of 38.97, a PEG ratio of 2.72 and a beta of 0.78. Danaher Corporation has a 1-year low of $160.93 and a 1-year high of $242.80.

Danaher (NYSE:DHR - Get Free Report) last announced its quarterly earnings data on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, beating the consensus estimate of $1.85 by $0.09. The company had revenue of $6.26 billion for the quarter, compared to the consensus estimate of $6.12 billion. Danaher had a net margin of 15.95% and a return on equity of 11.04%. Danaher's revenue for the quarter was up 5.5% on a year-over-year basis. During the same period in the prior year, the firm posted $0.77 EPS. As a group, equities analysts expect that Danaher Corporation will post 8.53 EPS for the current fiscal year.

Analyst Ratings Changes

A number of research firms have weighed in on DHR. Guggenheim reduced their target price on Danaher from $235.00 to $200.00 and set a "buy" rating on the stock in a report on Wednesday, July 22nd. Royal Bank Of Canada increased their price objective on Danaher from $200.00 to $215.00 and gave the stock an "outperform" rating in a report on Wednesday, July 22nd. TD Cowen lowered their price objective on Danaher from $240.00 to $236.00 and set a "buy" rating for the company in a research report on Wednesday, July 22nd. Deutsche Bank Aktiengesellschaft reaffirmed a "buy" rating and issued a $240.00 target price on shares of Danaher in a research report on Wednesday, July 22nd. Finally, Wells Fargo & Company dropped their price objective on shares of Danaher from $212.00 to $195.00 and set an "equal weight" rating on the stock in a research note on Wednesday, July 22nd. One analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and five have assigned a Hold rating to the company's stock. Based on data from MarketBeat, Danaher has a consensus rating of "Moderate Buy" and an average target price of $228.91.

Danaher Profile

Danaher Corporation NYSE: DHR is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher's portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source